Transaction DateRecipientSharesTypePriceValue
15th September 2020Advisors Llc Perceptive2,911,764Open or private purchase$4.25$12,374,997.00
14th September 2020Advisors Llc Perceptive400,000Open or private purchase$40.00$16,000,000.00
14th September 2020Advisors Llc Perceptive1,800,000Open or private purchase$11.00$19,800,000.00
10th September 2020Advisors Llc Perceptive200,000Open or private purchase$11.24$2,248,000.00
26th August 2020Dennis Reilly37,500Grant/award etc.$1.01$37,875.00
20th August 2020Sharon Barbari75,000Exercise of derivative$1.48$111,000.00
20th August 2020Alfred Altomari94,599Exercise of derivative$1.76$166,494.24
9th July 2020Advisors Llc Perceptive3,200,000Open or private purchase$4.25$13,600,000.00
22nd June 2020Alfred Altomari50,000Exercise of derivative$1.76$88,000.00
22nd June 2020Advisors Llc Perceptive1,750,000Open or private purchase$2.00$3,500,000.00
Agile Therapeutics
Agile Therapeutics logo

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

Ticker: AGRX
Sector: Health Technology
Industry: Pharmaceuticals: Other
SEC Central Index Key (CIK): 1261249
Employees: 15
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags